Clinical Trial Update: Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating how CYP2C9 genotype influences the efficacy and pharmacokinetics of piroxicam after lower third molar extraction, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impacted Third Molar Tooth
• Other Surgical Procedures
• Pain

Drugs mentioned

• Piroxicam (piroxicam)

Snippet

Sponsor: University of Sao Paulo | Conditions: Pain, Other Surgical Procedures | Phase 4 | Status: COMPLETED | Results posted: 2020-09-16